Chronic obstructive pulmonary disease (COPD) is projected to become the third leading
cause of death globally by 2030. Despite the limited treatment options available for …

Mucus hypersecretion resulting from excessive proliferation and metaplasia of goblet cells in
the airways is the pathological foundation for Chronic obstructive pulmonary disease …

A recent report by the World Health Organization revealed that three of the top five causes of
death in humans globally are lung related (1). At the fourth place, chronic obstructive …

The COPD is a very common, chronic, non-contagious disease causing high mortality as
well as high socio-economical costs worldwide. Its clinical assessment progressively …

Until now, interventional therapies for patients with chronic obstructive pulmonary disease
have been available in the form of lung volume reduction procedures as end-stage options …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of mortality in the
United States, behind cardiovascular and malignant disorders. It is also a common cause of …

Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity
and mortality worldwide. Preclinical models of COPD have recently been developed. In …

Chronic obstructive pulmonary disease (COPD) is characterized by the destruction of
alveolar tissue (in emphysema) and airway remodeling (leading to chronic bronchitis), which …

Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent and morbid disease
marked by irreversible structural changes in the lungs. Bronchoscopic therapies have …

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitations, that
are not fully reversible. COPD is a major cause of chronic morbidity and mortality throughout …